• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人常见眼病:识别并治疗视力丧失的原因。

Common eye diseases of elderly people: identifying and treating causes of vision loss.

作者信息

Harvey Patricia T

机构信息

Vision Science Research Programme, Toronto Western Hospital, Toronto, Canada.

出版信息

Gerontology. 2003 Jan-Feb;49(1):1-11. doi: 10.1159/000066507.

DOI:10.1159/000066507
PMID:12457044
Abstract

Of the 38 million people who are blind, the majority, 22 million, are 60 years of age or older. The most common causes of vision loss in elderly people are age-related macular degeneration (AMD), cataract, glaucoma, and diabetic retinopathy. Of these, AMD is the leading cause of registered blindness in people over the age of 50 years in the western world. However, until recently, the treatment options for people with AMD have been severely limited. Verteporfin therapy is a new treatment that is efficacious and safe in selected patients with AMD who are at high risk of central vision loss. Physicians who are in regular contact with elderly people can help to minimize vision loss in this group of patients by being alert to the symptoms and signs of age-related eye diseases. This paper reviews each of the common eye diseases, with an emphasis on AMD because of the recent advances in treatment.

摘要

在3800万盲人中,大多数(2200万)年龄在60岁及以上。老年人视力丧失的最常见原因是年龄相关性黄斑变性(AMD)、白内障、青光眼和糖尿病视网膜病变。其中,AMD是西方世界50岁以上人群登记失明的主要原因。然而,直到最近,AMD患者的治疗选择一直非常有限。维替泊芬疗法是一种新的治疗方法,对有中央视力丧失高风险的特定AMD患者有效且安全。经常接触老年人的医生可以通过留意年龄相关性眼病的症状和体征,帮助将这类患者的视力丧失降至最低。本文综述了每种常见眼病,由于治疗方面的最新进展,重点介绍了AMD。

相似文献

1
Common eye diseases of elderly people: identifying and treating causes of vision loss.老年人常见眼病:识别并治疗视力丧失的原因。
Gerontology. 2003 Jan-Feb;49(1):1-11. doi: 10.1159/000066507.
2
Vision Loss in Older Adults.老年人的视力丧失
Am Fam Physician. 2016 Aug 1;94(3):219-26.
3
Common causes of vision loss in elderly patients.老年患者视力丧失的常见原因。
Am Fam Physician. 1999 Jul;60(1):99-108.
4
Knowledge and beliefs about common eye diseases.关于常见眼病的知识和信念。
Aust N Z J Ophthalmol. 1997 Nov;25(4):283-7. doi: 10.1111/j.1442-9071.1997.tb01516.x.
5
Sight specific.视特定的。
Nurs Times. 1999;95(32):54-5.
6
Reducing vision loss in chronic eye disease.减少慢性眼病导致的视力丧失。
Aust Fam Physician. 2009 Oct;38(10):774-9.
7
Causes of vision loss worldwide, 1990-2010: a systematic analysis.全球视力丧失的原因,1990-2010 年:一项系统分析。
Lancet Glob Health. 2013 Dec;1(6):e339-49. doi: 10.1016/S2214-109X(13)70113-X. Epub 2013 Nov 11.
8
Epidemiology of eye diseases and infrastructure of ophthalmology in Poland.波兰的眼病流行病学与眼科学基础设施
Przegl Epidemiol. 2015;69(4):773-7, 905-8.
9
Geriatric vision loss due to cataracts, macular degeneration, and glaucoma.因白内障、黄斑变性和青光眼导致的老年视力丧失。
Mt Sinai J Med. 2012 Mar-Apr;79(2):276-94. doi: 10.1002/msj.21303.
10
Gradual loss of vision.视力逐渐丧失。
Aust Fam Physician. 1998 Mar;27(3):143-7.

引用本文的文献

1
Diabetes Care Disparities in Deaf/Hard of Hearing and Blind/Low Vision Populations.聋/听力障碍和盲/低视力人群中的糖尿病护理差异
Curr Diab Rep. 2024 Dec 30;25(1):14. doi: 10.1007/s11892-024-01565-z.
2
Retinal imaging with hand-held optical coherence tomography in older people with or without postoperative delirium after hip fracture surgery: A feasibility study.手持光学相干断层扫描在髋部骨折手术后伴有或不伴有术后谵妄的老年人中的视网膜成像:一项可行性研究。
PLoS One. 2024 Jul 16;19(7):e0305964. doi: 10.1371/journal.pone.0305964. eCollection 2024.
3
Public Awareness of Common Age-Related Eye Diseases in Northern Saudi Arabia.
沙特阿拉伯北部民众对常见年龄相关性眼病的认知
Cureus. 2024 Mar 24;16(3):e56841. doi: 10.7759/cureus.56841. eCollection 2024 Mar.
4
Understanding viewpoint changes in peripheral prisms for field expansion by virtual reality simulation.通过虚拟现实模拟理解用于视野扩展的周边棱镜中的视点变化。
Biomed Opt Express. 2024 Feb 2;15(3):1393-1407. doi: 10.1364/BOE.513758. eCollection 2024 Mar 1.
5
EyeCNN: exploring the potential of convolutional neural networks for identification of multiple eye diseases through retinal imagery.EyeCNN:通过视网膜图像探索卷积神经网络识别多种眼部疾病的潜力。
Int Ophthalmol. 2023 Oct;43(10):3569-3586. doi: 10.1007/s10792-023-02764-5. Epub 2023 Jun 8.
6
Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration.治疗新生血管性年龄相关性黄斑变性未满足需求的新兴策略。
J Transl Med. 2023 Feb 21;21(1):133. doi: 10.1186/s12967-023-03937-7.
7
Emerging Treatment Options for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration.年龄相关性黄斑变性继发地图样萎缩(GA)的新兴治疗选择
Clin Ophthalmol. 2023 Jan 23;17:321-327. doi: 10.2147/OPTH.S367089. eCollection 2023.
8
ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization.ANGPTL4 通过促进脉络膜新生血管形成来影响新生血管性年龄相关性黄斑变性患者的治疗反应。
JCI Insight. 2022 Jul 8;7(13):e157896. doi: 10.1172/jci.insight.157896.
9
Conditional knockout of hephaestin in the neural retina disrupts retinal iron homeostasis.条件性敲除神经视网膜中的赫菲斯塔司会破坏视网膜铁稳态。
Exp Eye Res. 2022 May;218:109028. doi: 10.1016/j.exer.2022.109028. Epub 2022 Mar 8.
10
Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy.眼内液蛋白有助于预测新生血管性年龄相关性黄斑变性患者对抗血管内皮生长因子治疗的反应。
J Clin Invest. 2022 Jan 18;132(2). doi: 10.1172/JCI144469.